Durable Capital Partners LP Sells 996,365 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• Durable Capital Partners LP reduced its holdings in Alignment Healthcare, Inc. by 21.7%, now owning approximately 3.59 million shares worth $66.8 million.
• Insider transactions revealed that two executives sold a combined total of 40,291 shares, with changes in ownership percentages for both insiders.
• Alignment Healthcare recently reported $1.02 billion in quarterly revenue, exceeding analyst estimates, and set a FY 2025 guidance for earnings per share (EPS).

Durable Capital Partners LP lessened its position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 21.7% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,589,745 shares of the company's stock after selling 996,365 shares during the quarter. Durable Capital Partners LP owned approximately 1.81% of Alignment Healthcare worth $66,841,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in ALHC. MetLife Investment Management LLC grew its stake in shares of Alignment Healthcare by 5.6% in the 4th quarter. MetLife Investment Management LLC now owns 61,344 shares of the company's stock worth $690,000 after buying an additional 3,256 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after buying an additional 6,286 shares during the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter worth approximately $317,000. The Manufacturers Life Insurance Company grew its stake in shares of Alignment Healthcare by 63.3% in the 4th quarter. The Manufacturers Life Insurance Company now owns 210,544 shares of the company's stock worth $2,369,000 after buying an additional 81,611 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of Alignment Healthcare by 8.6% in the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after buying an additional 72,063 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Insider Transactions at Alignment Healthcare

In other news, insider Robert L. Scavo sold 60,000 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $14.60, for a total value of $876,000.00. Following the transaction, the insider directly owned 642,953 shares in the company, valued at $9,387,113.80. This trade represents a 8.54% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO John E. Kao sold 180,000 shares of the firm's stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the transaction, the chief executive officer owned 1,553,100 shares in the company, valued at approximately $20,827,071. This trade represents a 10.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 636,185 shares of company stock worth $9,235,468. Company insiders own 7.00% of the company's stock.

Analyst Ratings Changes

ALHC has been the topic of several recent research reports. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research note on Monday, August 25th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Stock Performance

Shares of ALHC stock traded down $0.44 on Friday, reaching $15.86. The stock had a trading volume of 2,222,047 shares, compared to its average volume of 2,700,272. The stock has a market cap of $3.14 billion, a P/E ratio of -56.64 and a beta of 1.17. Alignment Healthcare, Inc. has a 1 year low of $8.65 and a 1 year high of $21.06. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The company has a 50 day simple moving average of $14.18 and a 200 day simple moving average of $15.42.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company's revenue for the quarter was up 49.0% on a year-over-year basis. During the same period last year, the business posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.